Ticagrelor: A Comprehensive Guide to its Properties, Applications, and Synthesis in Pharmaceutical Manufacturing
Discover the critical role of Ticagrelor in preventing thrombotic events and enhancing cardiovascular health.
Get a Quote & SampleProduct Core Value
Ticagrelor
Ticagrelor is a vital Active Pharmaceutical Ingredient (API) renowned for its efficacy as a P2Y12 platelet inhibitor. Its primary function is to prevent thrombotic events, making it a cornerstone in the treatment and management of cardiovascular diseases, particularly in patients experiencing acute coronary syndrome or those with a history of myocardial infarction. By reversibly binding to the P2Y12 receptor, it effectively inhibits ADP-mediated platelet activation and aggregation, thereby reducing the risk of serious cardiovascular outcomes.
- Explore the key indications for Ticagrelor, crucial for understanding its application in acute coronary syndrome and myocardial infarction recovery.
- Learn about the mechanism of action of Ticagrelor, detailing how it inhibits platelet aggregation to prevent blood clots.
- Understand the chemical properties of Ticagrelor, including its appearance as a white or off-white powder, essential for quality assessment in API manufacturing.
- Discover reliable Ticagrelor API manufacturing sources and understand the typical Ticagrelor supplier and price considerations for bulk purchases.
Benefits of Ticagrelor
Enhanced Cardiovascular Protection
Ticagrelor significantly reduces the rate of cardiovascular death, myocardial infarction, and stroke, offering robust protection for patients with serious cardiac conditions. Understanding the Ticagrelor indications is key to its effective therapeutic use.
Superior to Alternatives
In post-ACS patients, Ticagrelor has demonstrated superiority over clopidogrel, establishing it as a preferred treatment option. This performance underscores the importance of sourcing high-quality Ticagrelor powder.
Reduced Stent Thrombosis Risk
For patients who have undergone stenting procedures following ACS, Ticagrelor effectively lowers the risk of stent thrombosis, a critical factor in post-procedural patient care.
Key Applications
Acute Coronary Syndrome (ACS) Treatment
Ticagrelor is a primary treatment for patients with ACS, helping to prevent secondary events and improve recovery outcomes, highlighting its vital role in cardiac care.
Post-Myocardial Infarction (MI) Management
Patients with a history of MI benefit significantly from Ticagrelor's cardioprotective effects, reducing the risk of recurrent events and improving long-term prognosis.
Platelet Aggregation Inhibition
Its core mechanism of action involves inhibiting platelet aggregation, crucial for preventing the formation of dangerous blood clots in various cardiovascular conditions.
Pharmaceutical API Manufacturing
As a key API, Ticagrelor requires meticulous manufacturing processes to ensure purity and efficacy, making reliable Ticagrelor API manufacturers and suppliers essential for the industry.